Abstract

Near-infrared spectroscopy (NIRS) is a non-ionizing optical technique that can be used to quantify proteins, carbohydrates, fats, and other organic and biological substances. The aim of this study was to determine the ability of NIRS to identify different concentrations of L-fucose and L-proline solutions by utilizing different NIR spectral regions. NIR spectra of solid L-fucose and L-proline, their aqueous solutions in different concentrations, and the spectra of saliva samples collected from two patients with oral squamous cell carcinoma (OSCC) were studied. Differences in spectra of the pure solid reference samples and water were most noticeable in spectral regions 800–1250 nm and 1418–1867 nm. The saliva sample with an atypically high concentration of oral cancer biomarkers showed a similar spectral feature between 1530–1650 nm as the liquid samples with cancer biomarkers. In addition, a fine k-nearest neighbors (kNN) classifier was trained to differentiate the aqueous solutions and achieved 75.97% validation accuracy. The preliminary study presents that NIRS can be utilized to detect differences in spectra between the different biomarker concentrations in aqueous solutions. However, the qualitative measures may have resulted in limited sensitivity, which could be enhanced by additional samples and using a measurement probe dedicated to fluid measurements.

Highlights

  • Oral diseases threaten overall wellness and increase the risk for several systemic diseases

  • Saliva has high water content [34,35,36,45], and water is a strong NIR absorber. In this proofof-concept study, we aimed to identify the spectral regions for discriminating solutions with different concentrations of L-fucose and L-proline and water

  • Spectral peaks of L-fucose and L-proline are in line with the current literature of their molecular groups [62,63,64] (Tables 3 and 4)

Read more

Summary

Introduction

Oral diseases threaten overall wellness and increase the risk for several systemic diseases. The problem with diagnosing oral diseases is their overlapping symptoms. Optical methods based on fluorescence or chemiluminescence [1,2] can be used to confirm the presence of lesions but these methods cannot differentiate between low-risk and high-risk lesions [4,5]. Spectral cameras, such as VELScope, have not been able to distinguish between pre-malignant and malignant tissues more reliably than experienced

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.